<SEC-DOCUMENT>0001957912-26-000020.txt : 20260512
<SEC-HEADER>0001957912-26-000020.hdr.sgml : 20260512
<ACCEPTANCE-DATETIME>20260512171744
ACCESSION NUMBER:		0001957912-26-000020
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G/A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20260512
DATE AS OF CHANGE:		20260512

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Kezar Life Sciences, Inc.
		CENTRAL INDEX KEY:			0001645666
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				473366145
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-90539
		FILM NUMBER:		26969879

	BUSINESS ADDRESS:	
		STREET 1:		4000 SHORELINE COURT, SUITE 300
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		650-822-5600

	MAIL ADDRESS:	
		STREET 1:		4000 SHORELINE COURT, SUITE 300
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Baselake Partners, LP
		CENTRAL INDEX KEY:			0001957912
		ORGANIZATION NAME:           	
		EIN:				920901824
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		3155 W. BIG BEAVER ROAD, SUITE 207
		CITY:			TROY
		STATE:			MI
		ZIP:			48084
		BUSINESS PHONE:		(734) 649-4634

	MAIL ADDRESS:	
		STREET 1:		3155 W. BIG BEAVER ROAD, SUITE 207
		CITY:			TROY
		STATE:			MI
		ZIP:			48084

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Huron Associates, LP
		DATE OF NAME CHANGE:	20221212
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <schemaVersion>X0202</schemaVersion>
<headerData>
    <submissionType>SCHEDULE 13G/A</submissionType>
    <previousAccessionNumber>0001493152-26-015369</previousAccessionNumber>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001957912</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>1</amendmentNo>
      <securitiesClassTitle>Common Stock, $0.001 par value per share</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>05/11/2026</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001645666</issuerCik>
        <issuerName>Kezar Life Sciences, Inc.</issuerName>
        <issuerCusips>
          <issuerCusipNumber>49372L209</issuerCusipNumber>
        </issuerCusips>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>4000 Shoreline Court</com:street1>
          <com:street2>Suite 300</com:street2>
          <com:city>South San Francisco</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>94080</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(c)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>Baselake Partners, LP</reportingPersonName>
      <memberGroup>b</memberGroup>
      <citizenshipOrOrganization>DE</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0</soleVotingPower>
        <sharedVotingPower>0</sharedVotingPower>
        <soleDispositivePower>0</soleDispositivePower>
        <sharedDispositivePower>0</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>0</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>0</classPercent>
      <typeOfReportingPerson>PN</typeOfReportingPerson>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>
      <reportingPersonName>Baselake Management, LLC</reportingPersonName>
      <memberGroup>b</memberGroup>
      <citizenshipOrOrganization>DE</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0</soleVotingPower>
        <sharedVotingPower>0</sharedVotingPower>
        <soleDispositivePower>0</soleDispositivePower>
        <sharedDispositivePower>0</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>0</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>0</classPercent>
      <typeOfReportingPerson>IA</typeOfReportingPerson>
      <typeOfReportingPerson>OO</typeOfReportingPerson>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>
      <reportingPersonName>David Paolella</reportingPersonName>
      <memberGroup>b</memberGroup>
      <citizenshipOrOrganization>X1</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0</soleVotingPower>
        <sharedVotingPower>0</sharedVotingPower>
        <soleDispositivePower>0</soleDispositivePower>
        <sharedDispositivePower>0</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>391862</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>0</classPercent>
      <typeOfReportingPerson>HC</typeOfReportingPerson>
      <typeOfReportingPerson>IN</typeOfReportingPerson>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>Kezar Life Sciences, Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>4000 Shoreline Court, Suite 300
South San Francisco, California 94080</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>Baselake Partners, LP
Baselake Management, LLC
David Paolella</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>3155 W. Big Beaver Road, Suite 207, Troy, Michigan 48084</principalBusinessOfficeOrResidenceAddress>
        <citizenship>Baselake Partners, LP - Delaware
Baselake Management, LLC - Delaware
David Paolella - United States of America</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>Baselake Partners, LP - 0
Baselake Management, LLC - 0
David Paolella - 0</amountBeneficiallyOwned>
        <classPercent>Baselake Partners, LP - 0
Baselake Management, LLC - 0
David Paolella - 0</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>Baselake Partners, LP - 0
Baselake Management, LLC - 0
David Paolella - 0</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>Baselake Partners, LP - 0
Baselake Management, LLC - 0
David Paolella - 0</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>Baselake Partners, LP - 0
Baselake Management, LLC - 0
David Paolella - 0</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>Baselake Partners, LP - 0
Baselake Management, LLC - 0
David Paolella - 0</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>N</notApplicableFlag>
        <classOwnership5PercentOrLess>Y</classOwnership5PercentOrLess>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.</certifications>
      </item10>
    </items>
    <exhibitInfo>Exhibit I - JOINT FILING STATEMENT</exhibitInfo>
    <signatureInformation>
      <reportingPersonName>Baselake Partners, LP</reportingPersonName>
      <signatureDetails>
        <signature>/s/ David Paolella</signature>
        <title>David Paolella, Managing Member of Baselake Management, LLC, its investment manager</title>
        <date>05/12/2026</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>Baselake Management, LLC</reportingPersonName>
      <signatureDetails>
        <signature>/s/ David Paolella</signature>
        <title>David Paolella, Managing Member</title>
        <date>05/12/2026</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>David Paolella</reportingPersonName>
      <signatureDetails>
        <signature>/s/ David Paolella</signature>
        <title>Individually</title>
        <date>05/12/2026</date>
      </signatureDetails>
    </signatureInformation>
  </formData>

</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1
<SEQUENCE>2
<FILENAME>ex1.htm
<TEXT>
<!DOCTYPE html>
<html ><head></head><body style='font: 10pt Times New Roman, Times, Serif'>
<p style='text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt'><font style='font-family: Times New Roman, Times, Serif; font-size: 10pt'>&nbsp;</font></p>
<p style='font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right'><font style='font-family: Times New Roman, Times, Serif; font-size: 10pt'>Exhibit I</font></p>
<p style='font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center'><font style='font-family: Times New Roman, Times, Serif; font-size: 10pt'>&nbsp;</font></p>
<p style='font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center'><font style='font-family: Times New Roman, Times, Serif; font-size: 10pt'>JOINT FILING STATEMENT</font></p>
<p style='font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center'><font style='font-family: Times New Roman, Times, Serif; font-size: 10pt'>PURSUANT TO RULE 13D-1(K)(1)</font></p>
<p style='font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 67.5pt'><font style='font-family: Times New Roman, Times, Serif; font-size: 10pt'>&nbsp;</font></p>
<p style='font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify'><font style='font-family: Times New Roman, Times, Serif; font-size: 10pt'>The undersigned hereby consent and agree to the joint
filing of Schedule 13G under the Securities Exchange Act of 1934, as amended, with respect to the Shares of Kezar Life Sciences, Inc.
together with any or all amendments thereto, when and if required. The parties hereto further consent and agree to file this Joint Filing
Statement pursuant to Rule13d-1(k)(1)(iii) as an exhibit to Schedule 13G, thereby incorporating the same into such Schedule 13G.</font></p>
<p style='font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify'><font style='font-family: Times New Roman, Times, Serif; font-size: 10pt'>&nbsp;</font></p>
<p style='font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify'><font style='font-family: Times New Roman, Times, Serif; font-size: 10pt'>This Joint Filing Statement may be terminated by any
of the undersigned upon written notice or such lesser period of notice as the undersigned may mutually agree.</font></p>
<p style='font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify'><font style='font-family: Times New Roman, Times, Serif; font-size: 10pt'>&nbsp;</font></p>
<p style='font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify'><font style='font-family: Times New Roman, Times, Serif; font-size: 10pt'>Dated: May 12, 2026</font></p>
<p style='font: 10pt Times New Roman, Times, Serif; margin: 0pt'><font style='font-family: Times New Roman, Times, Serif; font-size: 10pt'>&nbsp;</font></p>
<table cellspacing='0' cellpadding='0' style='font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse'>
<tr style='font: 10pt Times New Roman, Times, Serif; vertical-align: top'><td><font style='font-family: Times New Roman, Times, Serif; font-size: 10pt'>&nbsp;</font></td>
<td colspan='2'><font style='font-family: Times New Roman, Times, Serif; font-size: 10pt'>Baselake Partners, LP</font></td></tr>
<tr style='font: 10pt Times New Roman, Times, Serif; vertical-align: top'><td style='width: 50%'>&nbsp;</td><td style='width: 3%'>&nbsp;</td><td style='width: 47%'>&nbsp;</td></tr>
<tr style='font: 10pt Times New Roman, Times, Serif; vertical-align: top'><td>&nbsp;</td><td>By:</td><td style='border-bottom: Black 1pt solid'><i>/s/
David Paolella</i></td></tr>
<tr style='font: 10pt Times New Roman, Times, Serif; vertical-align: top'><td>&nbsp;</td><td>&nbsp;</td><td>David Paolella, Managing Member of Baselake Management, LLC, its investment manager</td></tr>
<tr style='font: 10pt Times New Roman, Times, Serif; vertical-align: top'><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr>
<tr style='font: 10pt Times New Roman, Times, Serif; vertical-align: top'><td><font style='font-family: Times New Roman, Times, Serif; font-size: 10pt'>&nbsp;</font></td>
<td colspan='2'><font style='font-family: Times New Roman, Times, Serif; font-size: 10pt'>Baselake Management, LLC</font></td></tr>
<tr style='font: 10pt Times New Roman, Times, Serif; vertical-align: top'><td style='width: 50%'>&nbsp;</td><td style='width: 3%'>&nbsp;</td><td style='width: 47%'>&nbsp;</td></tr>
<tr style='font: 10pt Times New Roman, Times, Serif; vertical-align: top'><td>&nbsp;</td><td>By:</td><td style='border-bottom: Black 1pt solid'><i>/s/
David Paolella</i></td></tr>
<tr style='font: 10pt Times New Roman, Times, Serif; vertical-align: top'><td>&nbsp;</td><td>&nbsp;</td><td>David Paolella, Managing Member</td></tr>
<tr style='font: 10pt Times New Roman, Times, Serif; vertical-align: top'><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr>
<tr style='font: 10pt Times New Roman, Times, Serif; vertical-align: top'><td><font style='font-family: Times New Roman, Times, Serif; font-size: 10pt'>&nbsp;</font></td>
<td colspan='2'><font style='font-family: Times New Roman, Times, Serif; font-size: 10pt'>David Paolella</font></td></tr>
<tr style='font: 10pt Times New Roman, Times, Serif; vertical-align: top'><td style='width: 50%'>&nbsp;</td><td style='width: 3%'>&nbsp;</td><td style='width: 47%'>&nbsp;</td></tr>
<tr style='font: 10pt Times New Roman, Times, Serif; vertical-align: top'><td>&nbsp;</td><td>By:</td><td style='border-bottom: Black 1pt solid'><i>/s/
David Paolella</i></td></tr>
<tr style='font: 10pt Times New Roman, Times, Serif; vertical-align: top'><td>&nbsp;</td><td>&nbsp;</td><td>Individually</td></tr>
<tr style='font: 10pt Times New Roman, Times, Serif; vertical-align: top'><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr>
</table>
<div style='margin-bottom: 6pt; border-bottom: Black 1pt solid'><table cellpadding='0' cellspacing='0' style='border-collapse: collapse; width: 100%; font-size: 10pt'><tr style='vertical-align: top; text-align: left'><td style='text-align: left; width: 100%'>&nbsp;</td></tr></table></div>
<p style='font: 10pt Times New Roman, Times, Serif; margin: 0pt'><font style='font-family: Times New Roman, Times, Serif; font-size: 10pt'>&nbsp;</font></p>
</body></html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
